SCHEMBL22997742

SCHEMBL22997742

CSN1CCC(Nc2ncc(C(F)(F)F)c(-c3ncn(C)c3C)n2)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 16/20 0.72
▸ CCNE1 P24864 15/20 0.72
▸ CCND1 P24385 12/20 0.43
▸ CDK1 P06493 11/20 0.43
▸ CCNB1 P14635 11/20 0.43
▸ CDK6 Q00534 11/20 0.43
▸ CDK4 P11802 11/20 0.43
▸ CCND3 P30281 10/20 0.43
▸ ULK1 O75385 1/20 0.42
▸ CDK7 P50613 4/20 0.42
▸ CCNH P51946 4/20 0.42
▸ MNAT1 P51948 4/20 0.42
▸ CCNT1 O60563 4/20 0.42
▸ CDK9 P50750 4/20 0.42
▸ CCNA2 P20248 1/20 0.38
▸ CCNA1 P78396 1/20 0.38
▸ CCNK O75909 1/20 0.37
▸ CDK12 Q9NYV4 1/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ FLT3 P36888 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22997746 0.89 CCNE1 (0.58) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL23001263 0.89 CDK2 (0.58) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL22997728 0.87 CCNE1 (0.56) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL22976992 0.84 CCNE1 (1.00) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL22997726 0.84 CDK2 (0.74) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL26268744 0.82 CCNE1 (0.49) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL22997720 0.82 CCNE1 (0.55) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL22997662 0.81 CCNE1 (0.48) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL22997623 0.80 CDK2 (0.53) CDK2CCNE1CCND1CDK1CCNB1
SCHEMBL26267828 0.80 CDK2 (0.48) CDK2CCNE1CCND1CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021030537-A1 IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS INCYTE CORPORATION (US) 2021-02-18 — — WO disclosed
Send feedback